{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:53:21Z","timestamp":1697435601651},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1157\/13085017","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T11:49:00Z","timestamp":1153223340000},"page":"96-117","source":"Crossref","is-referenced-by-count":11,"title":["Recomendaciones de GEAM\/SPNS sobre el tratamiento de las alteraciones metab\u00f3licas y morfol\u00f3gicas en el paciente con infecci\u00f3n por VIH"],"prefix":"10.1016","volume":"24","author":[{"given":"Rosa","family":"Polo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u00aa","family":"Jos\u00e9 Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Manuel Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Asensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"C\u00e1noves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"C\u00e1ncer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Collazos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"G\u00f3mez-Candela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Locutura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"L\u00f3pez-Aldeguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Miralles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Mu\u00f1oz-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pascua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enric","family":"Pedrol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"San Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pompeyo","family":"Viciana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13085017_bib1","first-page":"25","article-title":"Guidelines to describe morphologic and metabolic alterations (MMA) under ART: the Marrakech classification","volume":"1","author":"Galli","year":"2001","journal-title":"Nutrition and Metabolic Disorders in HIV Infection"},{"key":"10.1157\/13085017_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1468-1293.2004.00191.x","article-title":"Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population","volume":"5","author":"Smith","year":"2004","journal-title":"HIV Med"},{"key":"10.1157\/13085017_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.20289","article-title":"Risk of diabetes in HIV infected veterans pre- and post- HAART and the role of HCV coinfection","volume":"40","author":"Butt","year":"2004","journal-title":"Hepatology"},{"key":"10.1157\/13085017_bib4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1157\/13085017_bib5","first-page":"472","article-title":"Bridging a gap: surgical management of HIV-associated lipoatrophy","volume":"14","author":"Moyle","year":"2004","journal-title":"AIDS Read"},{"issue":"Suppl 1","key":"10.1157\/13085017_bib6","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00002030-200304001-00017","article-title":"HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management","volume":"17","author":"Carr","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib7","first-page":"89","article-title":"Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV infection and its therapies","volume":"12","author":"Wohl","year":"2004","journal-title":"Top HIV Med"},{"key":"10.1157\/13085017_bib8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/380790","article-title":"Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL Study","volume":"38","author":"McComsey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodistrophy. A randomized, controlled trial","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1157\/13085017_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomized, doubleblind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"10.1157\/13085017_bib12","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib13","series-title":"Program and abstracts of the 11th Conference on Retroviruses on Opportunistic Infections","article-title":"Low-dose maintenance therapy with recombinant human hormone sustains effects of previous r-hGH treatment in HIV+ patients with excess center fat: treatment results at 60 weeks","author":"Kotler","year":"2004"},{"key":"10.1157\/13085017_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial","volume":"284","author":"Hadigan","year":"2000","journal-title":"JAMA"},{"key":"10.1157\/13085017_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-200402200-00013","article-title":"Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients","volume":"18","author":"Driscoll","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00126334-200210010-00006","article-title":"Improve insuline sensitivity and fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study","volume":"31","author":"Gelato","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13085017_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","article-title":"Rosiglitazone in the treatment of HAART-associated lipodystrophy- a randomized double-blind placebo-controlled study","volume":"8","author":"Sutinen","year":"2003","journal-title":"Antivir Ther"},{"key":"10.1157\/13085017_bib18","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1210\/jc.2002-020709","article-title":"Sustained benefits of metformin therapy on markes of cardiovascular risk in human inmunodeficiency virus-infected patients with fat redistribution and insulin resistance","volume":"87","author":"Hadigan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13085017_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00126334-200211010-00001","article-title":"Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an Internacional AIDS Society-USA Panel","volume":"31","author":"Schambelan","year":"2002","journal-title":"JAIDS"},{"key":"10.1157\/13085017_bib20","first-page":"147","article-title":"Alteraciones del metabolismo hidrocarbonado en el paciente VIH\/SIDA","volume":"17","author":"G\u00f3mez Candela","year":"2002","journal-title":"Nutrici\u00f3n Hospitalaria"},{"key":"10.1157\/13085017_bib21","unstructured":"Castro E, De Cos A, Iglesias C, G\u00f3mez Candela C. Alteraciones endocrinometab\u00f3licas en pacientes VIH positivos. En: Manual de Nutrici\u00f3n y Sida. Madrid; 2000. p. 56-79."},{"key":"10.1157\/13085017_bib22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/317491","article-title":"Disorders of glucose metabolism in patients with human inmunodeficiency virus","volume":"31","author":"Dube","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib23","series-title":"11th Conference on Retroviruses and Opportunistic Infections; 2004","article-title":"The Effect of Atazanavir vs Lopinavir\/ritonavir on Insulin-stimulated Glucose Disposal Rate in Healthy Subjets","author":"Noor","year":"2004"},{"key":"10.1157\/13085017_bib24","unstructured":"Iloeje U, Wu Y, Cislo P, Klleher T, Odeshoo L, Giordano M. Risk of Metabolic syndrome (metsyn) among Highly-treatment experienced HIV-infected patients- 48 week results from BMS studyAI 424045. In;2004;Bangkok; 2004."},{"key":"10.1157\/13085017_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib26","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moler","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13085017_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00002030-200304110-00010","article-title":"Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART","volume":"17","author":"Calza","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib28","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200108170-00007","article-title":"Dietary advice with or without pravastatin for the management of hypercholestrolaemia associated with protease inhibitor therapy","volume":"15","author":"Moyle","year":"2001","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib29","unstructured":"Masana L. Recomendaciones farmacol\u00f3gicas. F\u00e1rmacos hipolipemiantes. Interacciones farmacol\u00f3gicas. Gu\u00eda de manejo de la dislipemia en pacientes infectados por el VIH. [Informes, Gu\u00edas y Recomendaciones de la SEA] 2002 [Citado 1-12-2002]. Disponible en: http\/\/:www.searteriosclerosis.org."},{"key":"10.1157\/13085017_bib30","unstructured":"Harmonized clinical guidelines on prevention of atherosclerotic vascular disease. [homepage on the internet] International Atherosclerosis Society, [update 2002 Dec 1]. Disponible en: http\/\/www.searteriosclerosis.org"},{"key":"10.1157\/13085017_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002030-200203080-00008","article-title":"Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047","volume":"16","author":"Fichtenbaum","year":"2002","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/jinf.2001.0829","article-title":"Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administred drugs, and role of hypolipidaemic therapy with bezafibrate","volume":"42","author":"Manfredi","year":"2001","journal-title":"J Infect"},{"issue":"Suppl 2","key":"10.1157\/13085017_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/375884","article-title":"Bone disorders in human immunodeficiency virus infection","volume":"37","author":"Glesby","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1157\/13085017_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/367566","article-title":"Emerging bone problems in patients infected with human immunodeficiency virus","volume":"37","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib35","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is dependent of antirretroviral therapy","volume":"17","author":"Buera","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002030-200402200-00014","article-title":"Reduced bone density in HIV-infected women","volume":"18","author":"Dolan","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1157\/13085017_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1086\/367565","article-title":"Lactic acidemia in infection with human immunodeficiency virus","volume":"36","author":"Carr","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib39","unstructured":"AIDS Clinical Trials Group [homepage on the internet]. Hyperlactatemia acidosis. [updated 2002 Aug 13]. AACTG metabolic guides. Disponible en: http:\/\/aactg.s-3.com\/metabolic\/default.htm"},{"key":"10.1157\/13085017_bib40","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/339041","article-title":"Severe nucleoside-associated lactic acidosis in human immunodeficiency Virus- infected patients: report f 12 cases and review of the literature","volume":"34","author":"Falc\u00f3","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0025-7753(01)72001-5","article-title":"Hiperlactatemia sintom\u00e1tica en pacientes con infecci\u00f3n por el virus de la inmunodeficiencia humana tratados con an\u00e1logos de nucle\u00f3sidos","volume":"117","author":"Lozano","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13085017_bib42","unstructured":"Soler A, Deig E, Ribell M, P\u00e9rez M, Pedrol E. Consultas urgentes por efectos secundarios del tratamiento antirretroviral y su manejo. En: Pedrol E, Soler A, editores. Urgencias y VIH. Granollers, Barcelona, 2004."},{"key":"10.1157\/13085017_bib43","first-page":"561","article-title":"Spanish GESIDA\/National AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)","volume":"22","author":"Iribarren","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13085017_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1157\/13077376","article-title":"Tratamiento de la hiperlactatemia sintom\u00e1tica y de la acidosis l\u00e1ctica en pacientes con infecci\u00f3n por el virus de la inmunodeficiencia humana en tratamiento con inhibidores de la transcriptasa inversa an\u00e1logos de los nucle\u00f3sidos","volume":"125","author":"Pedrol","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13085017_bib45","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV- infected adults: case-control study","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1157\/13085017_bib46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","article-title":"An update coronary risk profile. A statement for health professionals","volume":"83","author":"Anderson","year":"1991","journal-title":"Circulation"},{"key":"10.1157\/13085017_bib47","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13085017_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trial for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"100","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1157\/13085017_bib49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodefiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1157\/13085017_bib50","series-title":"11th Conference on Retroviruses and opportunistic Infections","article-title":"Coronary revascularization in HIV-infected patients with coronary artery disease: a multicenter case control study","author":"Boccara","year":"2004"},{"key":"10.1157\/13085017_bib51","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)00593-0","article-title":"Sexual dysfunction with protease inhibitors","volume":"353","author":"Mart\u00ednez","year":"1999","journal-title":"Lancet"},{"key":"10.1157\/13085017_bib52","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00002030-200204120-00018","article-title":"Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy","volume":"16","author":"Collazos","year":"2002","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00126334-200211010-00008","article-title":"Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy","volume":"31","author":"Collazos","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13085017_bib54","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00002030-200206140-00016","article-title":"Association between sexual disturbances and sexual hormones with specific antiretroviral drugs","volume":"16","author":"Collazos","year":"2002","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00002030-200301030-00018","article-title":"Serum cortical in HIV-infected patients with and without highly active antiretroviral therapy","volume":"17","author":"Collazos","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib56","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/00365540410015231","article-title":"Cortisol serum levels and their relationship to certain antiretroviral drugs","volume":"36","author":"Collazos","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1157\/13085017_bib57","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00002030-200303280-00019","article-title":"Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era. Evidence of an interrelation between the thyroid axis and the immune system","volume":"17","author":"Collazos","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1310\/QAQQ-XTCJ-8AL4-6F5P","article-title":"Serum prolactin concentrations in patients infected with human immunodeficiency virus","volume":"3","author":"Collazos","year":"2002","journal-title":"HIV Clin Trials"},{"key":"10.1157\/13085017_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2710.1996.tb00006.x","article-title":"Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction","volume":"21","author":"Bruckert","year":"1996","journal-title":"J Clin Pharm Ther"},{"key":"10.1157\/13085017_bib60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/09540120050042927","article-title":"Sexual dysfunction in gay and bisexual men with HIV infection: evaluation, treatment and implications","volume":"12","author":"Catalan","year":"2000","journal-title":"AIDS Care"},{"key":"10.1157\/13085017_bib61","unstructured":"Sollima S, Osio M, Alciati A, d\u2019Arminio Monforte A, Zucconi M, Maga T, et al. Protease inhibitors and male impotence. XIII International Conference on AIDS. Durban, South Africa, July 9-14, 2000 [Abstract WePeB4216]."},{"key":"10.1157\/13085017_bib62","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/00002030-200105250-00010","article-title":"Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment","volume":"15","author":"Schrooten","year":"2001","journal-title":"AIDS"},{"key":"10.1157\/13085017_bib63","first-page":"149","article-title":"Cl\u00ednica de la obesidad","volume":"10","author":"Pav\u00f3n de Paz","year":"1999"},{"key":"10.1157\/13085017_bib64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/014860718701100108","article-title":"What is subjective global assessment of nutritional status?","volume":"11","author":"Detsky","year":"1987","journal-title":"JPEN"},{"key":"10.1157\/13085017_bib65","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1157\/13085017_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/367562","article-title":"Lipid abnormalities","volume":"36","author":"Dub\u00e9","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.290.4.502","article-title":"Effects of a dietary portfolio of Cholesterol-lowering foods vs lovastatin on serum levels and C-reactive protein","volume":"290","author":"Jenkins","year":"2003","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1157\/13085017_bib68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/367564","article-title":"Insulin and carbohydrate dysregulation","volume":"36","author":"Gelato","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1157\/13085017_bib69","first-page":"43","article-title":"American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus","volume":"23","year":"2000","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1157\/13085017_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/367566","article-title":"Emerging bone problems in patients infected with human immunodeficiency virus","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib71","first-page":"180","article-title":"Prevenci\u00f3n, dietas y tratamiento nutricional. Consejos diet\u00e9ticos, suplementos nutricionales y vitam\u00ednicos","volume":"2","author":"Johnston","year":"2002"},{"key":"10.1157\/13085017_bib72","series-title":"the development of the World Health Organisation Quality of Life instrument (WHOQOL) Gen\u00e8ve","year":"1993"},{"key":"10.1157\/13085017_bib73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1207\/S15327027HC1603_3","article-title":"Social support and management of uncertainty for people living with HIV or AIDS","volume":"16","author":"Brashers","year":"2004","journal-title":"Health Commun"},{"key":"10.1157\/13085017_bib74","first-page":"94","article-title":"Stigma in HIV-positive women j","volume":"23","author":"Sandelowski","year":"2004","journal-title":"Health Psychol"},{"key":"10.1157\/13085017_bib75","first-page":"928","article-title":"Emotional distress in nonmetropolitan persons living with HIV disease enrolled in a telephone-delivered, coping improvement group intervention","volume":"93","author":"Heckman","year":"2003","journal-title":"S Afr Med J"},{"key":"10.1157\/13085017_bib76","series-title":"Trastornos Mentales y del Comportamiento","year":"1992"},{"key":"10.1157\/13085017_bib77","series-title":"Manual diagn\u00f3stico y estad\u00edstico de los trastornos mentales Texto Revisado","year":"2002"},{"key":"10.1157\/13085017_bib78","unstructured":"Theodore Millon (con R. Davis). Trastornos de la personalidad M\u00e1s all\u00e1 del DSM-IV. Barcelona: Masson; 1998."},{"key":"10.1157\/13085017_bib79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11920-003-0083-4","article-title":"Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in human immunodefiency virus disease","volume":"5","author":"Cruess","year":"2003","journal-title":"Curr Psychiatry Rep"},{"key":"10.1157\/13085017_bib80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/09638280410001662932","article-title":"The health related quality of life of people living with HIV\/AIDS","volume":"26","author":"Hughes","year":"2004","journal-title":"Disabil Rehabil"},{"key":"10.1157\/13085017_bib81","series-title":"Cognitive therapy and the emotional disorders","author":"Beck","year":"1976"},{"key":"10.1157\/13085017_bib82","series-title":"Stress and survival: The emotional realities of life-threatening illness","article-title":"The Burnt-Out syndrome and patient care","author":"Maslach","year":"1999"},{"key":"10.1157\/13085017_bib83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00002508-200501000-00003","article-title":"Treatment expectancy affects the outcome of cognitive-behavioural interventions in chronic pain","volume":"21","author":"Goossens","year":"2005","journal-title":"Clin J Pain"},{"key":"10.1157\/13085017_bib84","first-page":"46","article-title":"Tratamiento psicol\u00f3gico cognitivo en pacientes VIH\/SIDA VII Congreso N","volume":"31","author":"C\u00e1noves","year":"2003","journal-title":"Psiquiatr Act Esp de Psiquiatr"},{"key":"10.1157\/13085017_bib85","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1086\/343050","article-title":"Switching effective antiretroviral therapy: a review","volume":"35","author":"Drechsler","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13085017_bib86","first-page":"47","article-title":"Switching antiretroviral drugs for treatment of metabolic complications in HIV-1 infection: summary of selected trials","volume":"10","author":"Saag","year":"2002","journal-title":"Topics HIV Med"},{"key":"10.1157\/13085017_bib87","unstructured":"Ar\u00e9valo JM, Del Pino V. Tratamiento quir\u00fargico integral del paciente con syndrome lipodistr\u00f3fico asociado al VIH. En: Polo R, coord. Actualizaci\u00f3n en el tratamiento de la lipodistrofia y alteraciones metab\u00f3licas. Madrid; 2003. p. 76-85."},{"key":"10.1157\/13085017_bib88","first-page":"L37","article-title":"Bio-Alcamid, a high-volume injectable prosthesis for facial reconstruction in HIV-related lipoatrophy: report on 100 patients","volume":"9","author":"Casavantes","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1157\/13085017_bib89","first-page":"L31","article-title":"Soft tissue augmentation with polymethymethacrylate (PMMA) for correction of lipodystrophy related body fat atrophy","volume":"9","author":"Serra","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1157\/13085017_bib90","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/01.PRS.0000056873.87165.5A","article-title":"Long term effects of polyacrylamide hydrogel in human breast tissue","volume":"101","author":"Christensen","year":"2003","journal-title":"Plat Reconstr Surg"},{"key":"10.1157\/13085017_bib91","first-page":"133","article-title":"Ultrasound assisted liposuction in 2002","volume":"8","author":"White","year":"2002","journal-title":"Operatives techniques in plastic and reconstructive surgery"},{"issue":"Suppl 4","key":"10.1157\/13085017_bib92","first-page":"68.","article-title":"The effects of polylactic acid in the therapy for the lipoatrophy of the face","volume":"6","author":"Polo","year":"2001","journal-title":"Antiviral Therapy"},{"key":"10.1157\/13085017_bib93","first-page":"L50","article-title":"Autologous fat transfer for the treatment of HIV-related face lipoatrophy: a long follow-up experience","volume":"9","author":"Guaraldi","year":"2004","journal-title":"Antiviral Therapy"},{"key":"10.1157\/13085017_bib94","first-page":"250","article-title":"Reconstruction of the buttocks in adult patients with chronic HIV-1 infection by means of submuscular anatomical implants of cohesive silicone gel","volume":"2","author":"Ar\u00e9valo","year":"2003","journal-title":"Nutr Metab Dis HIV Infect"},{"key":"10.1157\/13085017_bib95","first-page":"98","article-title":"Ultrasound assisted liposuction in adult patients with HIV-1 associated lipodystrophy syndrome","volume":"2","author":"Ar\u00e9valo","year":"2003","journal-title":"Nutr Metab Dis HIV Infect"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X06737363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X06737363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T03:30:59Z","timestamp":1683516659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X06737363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0213005X06737363"],"URL":"https:\/\/doi.org\/10.1157\/13085017","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}